Public health issues with Candida auris in COVID-19 patients
- PMID: 34909239
- PMCID: PMC8661744
- DOI: 10.1002/wmh3.472
Public health issues with Candida auris in COVID-19 patients
Abstract
The ongoing pandemic of coronavirus disease 2019 (COVID-19) has overwhelmed a number of medical facilities as well as a few entire health-care systems. A novel issue co-incident with the expeditious deployment of specialty care units for COVID-19 inpatients is the worldwide epidemic of Candida auris infections. Since its first identification and classification in Japan in 2009, it has spread globally. This threat was predicted as C. auris has a high mortality rate, cryptic fomite spread, frequent misidentification since conventional methods do not detect it, and multidrug-resistance. Since the April 2020 warning at the start of the COVID-19 pandemic in the United States, C. auris has been delineated as an increasingly consequential source of significant nosocomial infections, emphasizing the added hazard of C. auris to COVID-19 inpatients, particularly those in intensive care units.
Keywords: COVID‐19; Candida auris; nosocomial infections.
© 2021 Policy Studies Organization.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Similar articles
-
Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind.Dermatol Ther. 2020 Jul;33(4):e13481. doi: 10.1111/dth.13481. Epub 2020 May 27. Dermatol Ther. 2020. PMID: 32369240
-
A High Frequency of Candida auris Blood Stream Infections in Coronavirus Disease 2019 Patients Admitted to Intensive Care Units, Northwestern India: A Case Control Study.Open Forum Infect Dis. 2021 Sep 7;8(12):ofab452. doi: 10.1093/ofid/ofab452. eCollection 2021 Dec. Open Forum Infect Dis. 2021. PMID: 34904116 Free PMC article.
-
The Menace of Candida auris Epidemic Amidst the COVID-19 Pandemic: A Systematic Review.Diseases. 2022 Aug 29;10(3):58. doi: 10.3390/diseases10030058. Diseases. 2022. PMID: 36135214 Free PMC article. Review.
-
Impact of the COVID-19 Pandemic on Candida auris Infections: A Retrospective Analysis in an Academic Medical Center in New York City.Open Forum Infect Dis. 2024 Mar 19;11(6):ofae148. doi: 10.1093/ofid/ofae148. eCollection 2024 Jun. Open Forum Infect Dis. 2024. PMID: 38887476 Free PMC article.
-
Candida auris-the growing menace to global health.Mycoses. 2019 Aug;62(8):620-637. doi: 10.1111/myc.12904. Epub 2019 Jun 18. Mycoses. 2019. PMID: 30773703 Review.
Cited by
-
Preliminary Studies on the Mechanism of Antifungal Activity of New Cationic β-Glucan Derivatives Obtained from Oats and Barley.ACS Omega. 2022 Oct 27;7(44):40333-40343. doi: 10.1021/acsomega.2c05311. eCollection 2022 Nov 8. ACS Omega. 2022. PMID: 36385808 Free PMC article.
-
Pathobiology of Candida auris infection analyzed by multiplexed imaging and single cell analysis.PLoS One. 2024 Jan 17;19(1):e0293011. doi: 10.1371/journal.pone.0293011. eCollection 2024. PLoS One. 2024. PMID: 38232081 Free PMC article.
-
Global characteristics and trends in research on Candida auris.Front Microbiol. 2023 Dec 6;14:1287003. doi: 10.3389/fmicb.2023.1287003. eCollection 2023. Front Microbiol. 2023. PMID: 38125576 Free PMC article.
-
Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic.Microorganisms. 2022 Nov 10;10(11):2223. doi: 10.3390/microorganisms10112223. Microorganisms. 2022. PMID: 36363816 Free PMC article. Review.
-
Assessment of LAMPAuris for Rapid Detection of Candida auris in Clinical Specimens.Mycopathologia. 2024 Sep 23;189(5):87. doi: 10.1007/s11046-024-00892-9. Mycopathologia. 2024. PMID: 39312077
References
-
- de Almeida, J. N., Jr. , Francisco, E. C. , Hagen, F. , Brandão, I. B. , Pereira, F. M. , Presta Dias, P. H. , de Miranda Costa, M. M. , de Souza Jordão, R. T. , de Groot, T. , & Colombo, A. L. (2021). Emergence of Candida auris in Brazil in a COVID‐19 Intensive Care Unit. Journal of Fungi (Basel), 7(3), 220–220. 10.3390/jof7030220 - DOI - PMC - PubMed
-
- Borman, A. M. , Fraser, M. , & Johnson, E. M. (2021). CHROMagar™ Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris. Medical Mycology, 59(3), 253–258. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous